With respect to South Korea, Novartis solved certain perfectly-publicized allegations that it experienced made poor payments to HCPs in South Korea by means of spherical tables and third-party healthcare journals. Novartis Korea allegedly transmitted improper honoraria to HCPs for spherical tables through health care journals to avoid compliance sc